pyrroles has been researched along with Anxiety Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashiri, H; Kosari-Nasab, M; Sadeghi, T; Salari, AA; Shokouhi, G | 1 |
| Jia, J; Li, JT; Liao, XM; Liu, R; Schmidt, MV; Si, TM; Su, YA; Uribe-Mariño, A; Wang, XD; Xie, XM; Yang, XD | 1 |
| Avenet, P; Cohen, C; Depoortere, H; Evanno, Y; Françon, D; George, P; Granger, P; Griebel, G; Perrault, G; Scatton, B; Schoemaker, H; Sevrin, M; Simiand, J | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Basile, AS; Lippa, AS; Skolnick, P | 1 |
| Griebel, G; Perrault, G; Sanger, DJ | 1 |
2 review(s) available for pyrroles and Anxiety Disorders
| Article | Year |
|---|---|
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.
Topics: Amnesia, Anterograde; Animals; Anxiety Disorders; Ataxia; Central Nervous System; Discrimination Learning; Discrimination, Psychological; Drug Interactions; Drug Tolerance; Ethanol; GABA Agonists; GABA-A Receptor Agonists; Indoles; Mice; Pyrroles; Rats; Spasm; Substance-Related Disorders | 2003 |
Anxioselective anxiolytics: can less be more?
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepinones; Carbolines; Clinical Trials as Topic; Fluorobenzenes; GABA-A Receptor Agonists; Humans; Indoles; Pyrroles; Quinolones; Triazoles | 2004 |
4 other study(ies) available for pyrroles and Anxiety Disorders
| Article | Year |
|---|---|
The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Anxiety Disorders; Brain Concussion; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred Strains; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Stress, Physiological | 2019 |
Stress during a critical postnatal period induces region-specific structural abnormalities and dysfunction of the prefrontal cortex via CRF1.
Topics: Animals; Animals, Newborn; Anxiety Disorders; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Female; Hormone Antagonists; Male; Mice, Inbred C57BL; Prefrontal Cortex; Pyramidal Cells; Pyrimidines; Pyrroles; Random Allocation; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological | 2015 |
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.
Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones | 2004 |
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Buspirone; Diazepam; Male; Mice; Mice, Inbred BALB C; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone | 1998 |